160 related articles for article (PubMed ID: 17266196)
1. Pharmacophore-based design of sphingosine 1-phosphate-3 receptor antagonists that include a 3,4-dialkoxybenzophenone scaffold.
Koide Y; Uemoto K; Hasegawa T; Sada T; Murakami A; Takasugi H; Sakurai A; Mochizuki N; Takahashi A; Nishida A
J Med Chem; 2007 Feb; 50(3):442-54. PubMed ID: 17266196
[TBL] [Abstract][Full Text] [Related]
2. Identification of Leu276 of the S1P1 receptor and Phe263 of the S1P3 receptor in interaction with receptor specific agonists by molecular modeling, site-directed mutagenesis, and affinity studies.
Deng Q; Clemas JA; Chrebet G; Fischer P; Hale JJ; Li Z; Mills SG; Bergstrom J; Mandala S; Mosley R; Parent SA
Mol Pharmacol; 2007 Mar; 71(3):724-35. PubMed ID: 17170199
[TBL] [Abstract][Full Text] [Related]
3. Discovery of potent 3,5-diphenyl-1,2,4-oxadiazole sphingosine-1-phosphate-1 (S1P1) receptor agonists with exceptional selectivity against S1P2 and S1P3.
Li Z; Chen W; Hale JJ; Lynch CL; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Parent SA; Bergstrom J; Card D; Forrest M; Quackenbush EJ; Wickham LA; Vargas H; Evans RM; Rosen H; Mandala S
J Med Chem; 2005 Oct; 48(20):6169-73. PubMed ID: 16190743
[TBL] [Abstract][Full Text] [Related]
4. Highly selective and potent agonists of sphingosine-1-phosphate 1 (S1P1) receptor.
Vachal P; Toth LM; Hale JJ; Yan L; Mills SG; Chrebet GL; Koehane CA; Hajdu R; Milligan JA; Rosenbach MJ; Mandala S
Bioorg Med Chem Lett; 2006 Jul; 16(14):3684-7. PubMed ID: 16682185
[TBL] [Abstract][Full Text] [Related]
5. A prospective cross-screening study on G-protein-coupled receptors: lessons learned in virtual compound library design.
Sanders MP; Roumen L; van der Horst E; Lane JR; Vischer HF; van Offenbeek J; de Vries H; Verhoeven S; Chow KY; Verkaar F; Beukers MW; McGuire R; Leurs R; Ijzerman AP; de Vlieg J; de Esch IJ; Zaman GJ; Klomp JP; Bender A; de Graaf C
J Med Chem; 2012 Jun; 55(11):5311-25. PubMed ID: 22563707
[TBL] [Abstract][Full Text] [Related]
6. Selecting against S1P3 enhances the acute cardiovascular tolerability of 3-(N-benzyl)aminopropylphosphonic acid S1P receptor agonists.
Hale JJ; Doherty G; Toth L; Mills SG; Hajdu R; Keohane CA; Rosenbach M; Milligan J; Shei GJ; Chrebet G; Bergstrom J; Card D; Forrest M; Sun SY; West S; Xie H; Nomura N; Rosen H; Mandala S
Bioorg Med Chem Lett; 2004 Jul; 14(13):3501-5. PubMed ID: 15177461
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of conformationally constrained 3-(N-alkylamino)propylphosphonic acids as potent agonists of sphingosine-1-phosphate (S1P) receptors.
Yan L; Hale JJ; Lynch CL; Budhu R; Gentry A; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Bergstrom J; Card D; Rosen H; Mandala SM
Bioorg Med Chem Lett; 2004 Oct; 14(19):4861-6. PubMed ID: 15341940
[TBL] [Abstract][Full Text] [Related]
8. Constrained azacyclic analogues of the immunomodulatory agent FTY720 as molecular probes for sphingosine 1-phosphate receptors.
Hanessian S; Charron G; Billich A; Guerini D
Bioorg Med Chem Lett; 2007 Jan; 17(2):491-4. PubMed ID: 17070046
[TBL] [Abstract][Full Text] [Related]
9. Discovery of nonpeptidic small-molecule AP-1 inhibitors: lead hopping based on a three-dimensional pharmacophore model.
Tsuchida K; Chaki H; Takakura T; Kotsubo H; Tanaka T; Aikawa Y; Shiozawa S; Hirono S
J Med Chem; 2006 Jan; 49(1):80-91. PubMed ID: 16392794
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine 1-phosphate (S1P) induces shape change in rat C6 glioma cells through the S1P2 receptor: development of an agonist for S1P receptors.
Kim K; Kim YL; Sacket SJ; Kim HL; Han M; Park DS; Lee BK; Lee WK; Ha HJ; Im DS
J Pharm Pharmacol; 2007 Jul; 59(7):1035-41. PubMed ID: 17637200
[TBL] [Abstract][Full Text] [Related]
11. BML-241 fails to display selective antagonism at the sphingosine-1-phosphate receptor, S1P(3).
Jongsma M; Hendriks-Balk MC; Michel MC; Peters SL; Alewijnse AE
Br J Pharmacol; 2006 Oct; 149(3):277-82. PubMed ID: 16940990
[TBL] [Abstract][Full Text] [Related]
12. First pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening.
Jain V; Saravanan P; Arvind A; Mohan CG
Chem Biol Drug Des; 2011 May; 77(5):373-87. PubMed ID: 21284830
[TBL] [Abstract][Full Text] [Related]
13. Discovery of 3-arylpropionic acids as potent agonists of sphingosine-1-phosphate receptor-1 (S1P1) with high selectivity against all other known S1P receptor subtypes.
Yan L; Huo P; Doherty G; Toth L; Hale JJ; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Bergstrom J; Card D; Quackenbush E; Wickham A; Mandala SM
Bioorg Med Chem Lett; 2006 Jul; 16(14):3679-83. PubMed ID: 16697189
[TBL] [Abstract][Full Text] [Related]
14. Pyrazole derived from (+)-3-carene; a novel potent, selective scaffold for sphingosine-1-phosphate (S1P(1)) receptor agonists.
Zécri FJ; Albert R; Landrum G; Hinterding K; Cooke NG; Guerini D; Streiff M; Bruns C; Nuesslein-Hildesheim B
Bioorg Med Chem Lett; 2010 Jan; 20(1):35-7. PubMed ID: 19954976
[TBL] [Abstract][Full Text] [Related]
15. 2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists.
Bolli MH; Abele S; Binkert C; Bravo R; Buchmann S; Bur D; Gatfield J; Hess P; Kohl C; Mangold C; Mathys B; Menyhart K; Müller C; Nayler O; Scherz M; Schmidt G; Sippel V; Steiner B; Strasser D; Treiber A; Weller T
J Med Chem; 2010 May; 53(10):4198-211. PubMed ID: 20446681
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation-independent internalisation and desensitisation of the human sphingosine-1-phosphate receptor S1P3.
Rutherford C; Ord-Shrimpton FU; Sands WA; Pediani JD; Benovic JL; McGrath JC; Palmer TM
Cell Signal; 2005 Aug; 17(8):997-1009. PubMed ID: 15894172
[TBL] [Abstract][Full Text] [Related]
17. The discovery of 3-(N-alkyl)aminopropylphosphonic acids as potent S1P receptor agonists.
Hale JJ; Doherty G; Toth L; Li Z; Mills SG; Hajdu R; Ann Keohane C; Rosenbach M; Milligan J; Shei GJ; Chrebet G; Bergstrom J; Card D; Rosen H; Mandala S
Bioorg Med Chem Lett; 2004 Jul; 14(13):3495-9. PubMed ID: 15177460
[TBL] [Abstract][Full Text] [Related]
18. S1P receptor signalling and RGS proteins; expression and function in vascular smooth muscle cells and transfected CHO cells.
Hendriks-Balk MC; van Loenen PB; Hajji N; Michel MC; Peters SL; Alewijnse AE
Eur J Pharmacol; 2008 Dec; 600(1-3):1-9. PubMed ID: 18854184
[TBL] [Abstract][Full Text] [Related]
19. Discovery of oxazole and triazole derivatives as potent and selective S1P(1) agonists through pharmacophore-guided design.
Tian Y; Jin J; Wang X; Hu J; Xiao Q; Zhou W; Chen X; Yin D
Eur J Med Chem; 2014 Oct; 85():1-15. PubMed ID: 25072873
[TBL] [Abstract][Full Text] [Related]
20. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin.
González-Díez M; Rodríguez C; Badimon L; Martínez-González J
Thromb Haemost; 2008 Jul; 100(1):119-26. PubMed ID: 18612546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
